Perflubron as a gastrointestinal MR imaging contrast agent in the pediatric population

Pediatric Radiology

Volumn 26, Issue 6, 1996, Pages 409-415

  Bisset III, G S ^a   Emery, K H ^b   Meza, M P ^c   Rollins, N K ^d   Don, S ^e   Shorr, J S ^f  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Alliance Pharmaceutical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; PERFLUOROOCTYL BROMIDE;

ABDOMEN; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HUMAN; LIVER; MALE; MESENTERY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PANCREAS; PELVIS; PRIORITY JOURNAL;

EID: 0029893065     PISSN: 03010449     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01387316     Document Type: Article

References (21)

1. Bisset GS (1989) Evaluation of potential practical oral contrast agents for pediatric magnetic resonance imaging. Preliminary observations. Pediatr Radiol 20: 61-66
2. Brown JJ, Duncan JR, Heiken JP, et al (1991) Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 181: 455-460
3. Patten RM, Lo SK, Phillips JJ, et al (1993) Positive bowel contrast agent for MR imaging of the abdomen: phase-II and -III clinical trials. Radiology 189: 277-283
4. Tart RP, Li KC, Storm BL, Rolfes RJ, Ang PG (1991) Enteric MRI contrast agents: comparative study of five potential agents in humans. Magn Reson Imaging 9: 559-568
5. Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann HJ, Felix R (1988) MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR 150: 817-821
6. Mattrey RF, Hajek PC, Gylys-Morin VM, et al (1987) Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans. AJR 148: 1259-1263
7. Bach Gansmo T, Dupas B, Gayet Delacroix M, Lambrechts M (1993) Abdominal MRI using a negative contrast agent. Br J Radiol 66: 420-425
8. Mattrey KP, Trambert MA, Brown JJ, et al (1994) Perflubrom as an oral contrast agent for MR imaging: results of a phase-III clinical trial. Radiology 191: 841-848
9. Listinsky JJ, Bryant RG (1988) Gastrointestinal contrast agents: a diamagnetic approach. Magn Reson Med 8: 285-292
10. Van Beers B, Grandin C, Jamart J, Demeure R, Jacobsen TF, Pringot J (1992) Magnetic resonance imaging of lower abdominal and pelvic lesions: assessment of oral magnetic particles as an intestinal contrast agent. Eur J Radiol 14: 252-257
11. Rubin DL, Muller HH, Nino Murcia M, Sidhu M, Christy V, Young SW (1991) Intraluminal contrast enhancement and MR visualization of the bowel wall: efficacy of PFOB. JMRI1: 371-380
12. Kaminsky S, Laniado M, Gogoll M, et al (1991) Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 178: 503-508
13. Hahn PF, Stark DD, Lewis JM, et al (1990) First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 175: 695-700
14. Lonnemark M, Hemmingsson J, Carlsten J, Ericsson A, Holtz E, Ktaveness J (1988) Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract. Acta Radiol 19: 599-602
15. Li KC, Ang PG, Tart RP, Storm BL, Rolfes R, Ho Tai PC (1990) Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents. Magn Reson Imaging 8: 589-598
16. Nunnally R (1984) Improved MR imaging of the upper abdomen with glucagon and gas. J Comput Assist Tomogr 8: 835-838
17. Pels Rijcken TH, Davis MA, Ros PR (1994) Intraluminal contrast agents for MR imaging of the abdomen and pelvis. J Magn Reson Imaging 4: 291-300
18. Li KCP, Tart RP, Fitzsimmons JR, Storm BL, Mao J, Rolfes RJ (1991) Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies. Magn Reson Imaging 9: 141-150
19. Marti Bonmati L, Vilar U, Paniagua JC, Talens A (1991) High-density barium sulphate as an MRI oral contrast. Magn Reson Imaging 9: 259-261
20. Hahn PE Stark DD, Saini S, Lewis JM, Wittenberg J, Ferrucci JT (1987) Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies. Radiology 164: 37-41
21. Schumacher DJ, Steinbach G, Keane S, Buxton RB, Unger E, Mattrey RF (1991) Comparison of artifacts generated by oral MRI contrast agents in vitro. Invest Radiol 26 [Suppl]: 1125